Lanluma V 1x15ml is an injectable PLLA biostimulator designed to restore volume and stimulate long-term collagen production. Ideal for facial and body treatments requiring natural, progressive rejuvenation with results lasting up to 24 months.
Pricing is available to registered aesthetic professionals only.
Sign in to view pricesLanluma V 1x15ml is a professional injectable poly-L-lactic acid (PLLA) biostimulatory treatment designed to restore volume, improve skin firmness, and stimulate long-term collagen production. Supplied as a sterile powder vial containing 210 mg PLLA, Lanluma V is reconstituted prior to injection and is intended for deep dermal and subcutaneous use in face and body treatments.
Unlike hyaluronic acid fillers that provide immediate volume through gel implantation, Lanluma V works by stimulating the body’s natural collagen synthesis, delivering progressive, natural-looking volume restoration and skin quality improvement over time.
Lanluma V belongs to the category of collagen-stimulating injectables and is clinically comparable to other PLLA-based biostimulators such as Sculptra®. These products focus on bioremodeling and volumization through neocollagenesis, rather than direct filling.
This comparison is provided for professional reference only and does not imply interchangeability.
According to manufacturer documentation, Lanluma V 1x15ml is indicated for:
Treatment areas:
Face (cheeks, temples, jawline)
Mid-face volume loss
Body contouring (buttocks, hips, thighs)
Skin laxity and collagen depletion
Volume restoration following aging or weight loss
→ Lanluma V is particularly suited for patients seeking long-lasting volume correction and structural support with gradual, natural results.
Injection depth: Deep dermal to subcutaneous plane
Product preparation: Requires reconstitution with sterile water for injection (volume as per IFU)
Injection technique: Cannula or needle using fanning or cross-hatching techniques
Treatment protocol: Typically 1–3 sessions spaced 4–6 weeks apart
Longevity: Results develop gradually over weeks and can last up to 24 months
Professional-use disclaimer: For use only by trained and qualified medical or aesthetic practitioners
If any parameter is not explicitly stated in the official IFU, it is considered not provided by the manufacturer.
Poly-L-lactic acid (PLLA): 210 mg
Sodium carboxymethylcellulose
Mannitol
Lanluma V does not contain lidocaine. Reconstitution and dilution must follow official manufacturer instructions.
Presentation: 1 Ă— 15 ml vial (powder form)
Reconstitution: Required prior to use
Shelf life: Refer to packaging for expiry date
Treatment longevity: Progressive collagen stimulation with results lasting up to 18–24 months, depending on patient factors and protocol
Contraindicated in patients with hypersensitivity to PLLA or any excipients
Do not inject into areas with active infection or inflammation
Not suitable for intravascular injection
Strict aseptic technique required
Practitioner must have advanced anatomical knowledge and biostimulator training
CE-marked medical device in applicable regions. Regulatory classification, approved indications, and usage protocols may vary by country. Practitioners should always consult the official IFU and comply with local regulations.
Lanluma V is used for collagen stimulation, volume restoration, and skin firmness improvement in both facial and body treatments.
Lanluma V contains PLLA, which stimulates fibroblasts to produce new collagen over time. This leads to gradual volumization and improved skin structure rather than immediate filling.
No. Lanluma V is a biostimulator, not a traditional filler. It works progressively by inducing collagen production rather than instantly adding volume.
Results typically last 18 to 24 months, depending on patient metabolism, treatment area, and number of sessions.
Advanced injector training is strongly recommended. Proper education in PLLA reconstitution, injection technique, and anatomy is essential for safe and effective outcomes.
Let’s talk on WhatsApp